£78.85

This is the most expensive it has ever been. Walk away.

£79 today · previous high £79 · all-time low £79

Springer Cancer Therapy: Monoclonal Antibodies, Lymphokines New Developments in Surgical Oncology and Chemo- and Hormonal Therapy

Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 51 days · 51 data points (no recent data)

Historical
Generating forecast…
£78.85 £78.81 £78.82 £78.83 £78.83 £78.84 £78.85 25 July 2026 06 August 2026 19 August 2026 31 August 2026 13 September 2026
View at Amazon ↗

Price data last checked 40 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 51 days • 1 price levels

Days at Price
51 days 0 13 26 38 51 £79 Days at Price

Price Analysis

Most common price: £79 (51 days, 100.0%)

Price range: £79 - £79

Price levels: 1 different prices over 51 days

Description

A variety of new cancer therapy modalities are discussed and evaluated in this book. It aims to demonstrate that the combination of classical chemo- and radiotherapy with new approaches in the field of immunotherapy can result in an improved treatment modality. Immunotherapy in this context consists of therapy with monoclonal antibodies, hematopoietic growth factors and other lymphokines. Results of early clinical trials with IL-2, GM-CSF and monoclonal antibodies against gastrointestinal tumors and melanoma are included. The progress in regional chemotherapy strategies, for example of the liver, is shown. In addition, the development of new chemotherapeutic agents with a different mode of action as well as better tolerability is presented. The use of hormones, such as LH-RH agonists, allows hormone-dependent tumors such as prostatic and breast cancer to be treated without strong adverse reactions. These recent findings give the reader insight into exciting therapeutic directions made possible by such combined, rather than single, modalities.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
22 November 2011
Listed Since
13 July 2012

Barcode

No barcode data available

Similar Products You Might Like

Current Immunotherapeutic Strategies in Cancer: 214 (Recent Results in Cancer Research, 214)
97% match

Current Immunotherapeutic Strategies in Cancer: 214 (Recent Results in Cancer Research, 214)

Springer

£87.93 01 Oct 2026
Wiley A Beginner's Guide to Targeted Cancer Treatments
97% match

Wiley A Beginner's Guide to Targeted Cancer Treatments

Wiley

£44.89 26 Sep 2026
Immunotherapy of Cancer (Cancer Drug Discovery and Development)
97% match

Immunotherapy of Cancer (Cancer Drug Discovery and Development)

Humana

£70.98 24 Sep 2026
Immunotherapy of Cancer: Innovative Treatment Comes of Age
97% match

Immunotherapy of Cancer: Innovative Treatment Comes of Age

Springer

£106.33 02 Oct 2026
Immunotherapy of Cancer: Methods and Protocols: 651 (Methods in Molecular Biology, 651)
97% match

Immunotherapy of Cancer: Methods and Protocols: 651 (Methods in Molecular Biology, 651)

Humana

£74.21 23 Sep 2026
Tumor Immunology: Methods and Protocols: 1393 (Methods in Molecular Biology, 1393)
97% match

Tumor Immunology: Methods and Protocols: 1393 (Methods in Molecular Biology, 1393)

Humana

£69.37 22 Sep 2026
Critical Developments in Cancer Immunotherapy
97% match

Critical Developments in Cancer Immunotherapy

£421.00 01 Oct 2026
Immuno-Oncology: Cellular and Translational Approaches (Methods in Pharmacology and Toxicology)
97% match

Immuno-Oncology: Cellular and Translational Approaches (Methods in Pharmacology and Toxicology)

Humana

£84.27 18 Sep 2026
Developments in T Cell Based Cancer Immunotherapies (Cancer Drug Discovery and Development)
97% match

Developments in T Cell Based Cancer Immunotherapies (Cancer Drug Discovery and Development)

Humana

£108.01 27 Aug 2026
Immunotherapy in Translational Cancer Research (Translational Oncology)
97% match

Immunotherapy in Translational Cancer Research (Translational Oncology)

Wiley

£130.00 22 Aug 2026
The MD Anderson Manual of Medical Oncology, Fourth Edition
97% match

The MD Anderson Manual of Medical Oncology, Fourth Edition

McGraw-Hill Education

£170.00 21 Aug 2026
Cancer Chemotherapy, Immunotherapy, and Biotherapy
97% match

Cancer Chemotherapy, Immunotherapy, and Biotherapy

Lippincott Williams & Wilkins

£162.71 28 Aug 2026
Cancer Immunoprevention: Methods and Protocols: 2435 (Methods in Molecular Biology, 2435)
96% match

Cancer Immunoprevention: Methods and Protocols: 2435 (Methods in Molecular Biology, 2435)

Humana

£109.99 17 Sep 2026
Cancer Immunology and Immunotherapy: 344 (Current Topics in Microbiology and Immunology, 344)
96% match

Cancer Immunology and Immunotherapy: 344 (Current Topics in Microbiology and Immunology, 344)

Springer

£143.27 24 Sep 2026
Immune Mediators in Cancer: Methods and Protocols: 2108 (Methods in Molecular Biology)
96% match

Immune Mediators in Cancer: Methods and Protocols: 2108 (Methods in Molecular Biology)

Humana

£92.38 11 Sep 2026
Immunotherapy of Cancer (Volume 128) (Advances in Cancer Research, Volume 128)
96% match

Immunotherapy of Cancer (Volume 128) (Advances in Cancer Research, Volume 128)

Elsevier

£116.99 24 Sep 2026
Basic and Clinical Tumor Immunology: 14 (Cancer Treatment and Research)
96% match

Basic and Clinical Tumor Immunology: 14 (Cancer Treatment and Research)

Springer

£158.92 30 Sep 2026
Biomarkers for Immunotherapy of Cancer: Methods and Protocols: 2055 (Methods in Molecular Biology, 2055)
96% match

Biomarkers for Immunotherapy of Cancer: Methods and Protocols: 2055 (Methods in Molecular Biology, 2055)

Humana

£110.83 22 Sep 2026
Mechanisms of Tumor Escape from the Immune Response (Tumor Immunology and Immunotherapyseries, 1)
96% match

Mechanisms of Tumor Escape from the Immune Response (Tumor Immunology and Immunotherapyseries, 1)

CRC Press

£79.41 23 Sep 2026
Side Effects of Medical Cancer Therapy: Prevention and Treatment
96% match

Side Effects of Medical Cancer Therapy: Prevention and Treatment

Springer

£89.28 26 Sep 2026
Immunoconjugate Therapy of Hematologic Malignancies: 68 (Cancer Treatment and Research, 68)
96% match

Immunoconjugate Therapy of Hematologic Malignancies: 68 (Cancer Treatment and Research, 68)

Springer

£179.99 30 Sep 2026
New Trends in the Molecular and Biological Basis for Clinical Oncology
96% match

New Trends in the Molecular and Biological Basis for Clinical Oncology

Springer

£77.89 18 Sep 2026